<DOC>
	<DOCNO>NCT02151214</DOCNO>
	<brief_summary>In malnourished patient palliative phase cancer , question raise relevance implement artificial nutritional assistance instead oral feed possible . Medical prescription implementation artificial nutrition stage illness seem less governed data acquire science subjective reason ( related belief , cultural religious tradition , symbolic role eating , deeply ingrained fear die hunger , portrayal care , etc . ) interact team , patient family relative . And yet , benefits/risk balance effect quality life parenteral nutrition palliative situation patient present normal alimentary tract poorly understood . The discomfort risk central venous nasogastric artificial nutrition require benefit artificial nutrition proven . The nature benefit relate first foremost quality life experience patient context . Only control randomize study may lead optimal palliative nutritional management undernutrition determine , inform patient his/her relatives clearly order express preference . We hypothesize abstain artificial parenteral central venous nutrition associate hydration nutritional purpose improve quality life without significant loss survival compare implement artificial nutrition , consider , absence specific curative treatment anorexic patient palliative phase cancer . To test hypothesis , propose carry multicenter , prospective , control , randomize study order evaluate efficacy implement parenteral nutrition compare abstain quality life undernourish patient palliative phase cancer . The effect overall survival nutritional parameter evaluate . The ALIM K trial carry 12 centre specialize supportive onco-hematology care .</brief_summary>
	<brief_title>Efficacy Parenteral Nutrition Patients Palliative Phase Cancer .</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : adult patient ( age &gt; 18 year ) suffer cancer palliative stage , i.e . patient main aim treatment limit pain discomfort curative treatment either discontinue , may still ongoing little expected benefit term overall survival patient must functional digestive tract present malnutrition define body mass index ( BMI ) &lt; 18.5 kg/m² patient age &lt; 70 year &lt; 21 kg/m² patient age ≥70 year ; weight loss 2 % 1 week , 5 % 1 month , 10 % 6 month patient antalgic radiotherapy schedule undergo palliative surgery patient must already functional central venous catheter place nonfunctional digestive tract ( intestinal occlusion , tumor compression , subocclusive peritoneal carcinosis ) ; disorder prevent oral ingestion ( cancer upper aerodigestive tract , oesophagus stomach ) ; life expectancy le 1 month parenteral nutrition ongoing date less one month ; intravenous chemotherapy pump last &gt; 48 hour incompatible administration parenteral nutritional central venous line ; presence gastrostomy jejunostomy ; persist sensation hunger aphagic patient patient haematological cancer undergo bonemarrow transplant , patient acute renal failure ( defined creatinine clearance &lt; 30 ml/min ) heart failure ( define leave ventricular ejection fraction &lt; 30 % ) ; adult patient legal guardianship unable respond quality life questionnaire ( due psychiatric disorder , attention disorder , cognitive disorder ) patient participate another ongoing clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Palliative Phase Cancer</keyword>
	<keyword>Quality life</keyword>
	<keyword>Parenteral nutrition</keyword>
	<keyword>Undernutrition</keyword>
</DOC>